Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study model. (2014)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.leukres.2013.10.014
PubMed Identifier: 24360612
Publication URI: http://europepmc.org/abstract/MED/24360612
Type: Journal Article/Review
Volume: 38
Parent Publication: Leukemia research
Issue: 2
ISSN: 0145-2126